(Q46875995)

26 December 2017

title

A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis (English)

1 reference

26 December 2017

main subject

multiple sclerosis

0 references

author

Stavros J. Baloyannis

3

object named as

S Baloyannis

1 reference

26 December 2017

author name string

L Logothetis

1

1 reference

26 December 2017

I A Mylonas

2

1 reference

26 December 2017

M Pashalidou

4

1 reference

26 December 2017

A Orologas

5

1 reference

26 December 2017

A Zafeiropoulos

6

1 reference

26 December 2017

V Kosta

7

1 reference

26 December 2017

T C Theoharides

8

1 reference

26 December 2017

publication date

1 October 2005

1 reference

26 December 2017

International Journal of Immunopathology and Pharmacology

published in

1 reference

26 December 2017

volume

18

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

771-778

1 reference

26 December 2017

The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

The mast cells of the multiple sclerosis brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Psychological stress and the subsequent appearance of new brain MRI lesions in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Critical role of mast cells in inflammatory diseases and the effect of acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: possible relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Mast cells: the immune gate to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Inflammatory mediators and modulation of blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Brain mast cell degranulation regulates blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Mast cells: new targets for multiple sclerosis therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800421

10.1177/039463200501800421

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017